Cancer cell-expressed MUC1 can be modified by multiple short, sialylated O-linked glycans, which can engage SIGLEC-9 and consequently induce calcium flux and MEK-ERK activation, leading to TAM-like phenotype [17]. The gene discussed is MAP2K7; the disease is cancer.